Abbott Nutrition Manufacturing

What Abbott Nutrition Manufacturing does

Abbott Nutrition Manufacturing is a division of Abbott Laboratories (NYSE: ABT), a diversified healthcare company founded in 1888 and headquartered in Illinois. Operating manufacturing sites in Columbus, Ohio and Sturgis, Michigan, the division develops, produces, and markets science-based nutritional products spanning infant formula (Similac), pediatric growth nutrition (PediaSure), adult nutrition (Ensure, Glucerna, Nepro, PROTALITY), rehydration (Pedialyte), hypoallergenic amino acid-based formulas (EleCare, EleCare Jr, Similac Alimentum), wound healing supplements (Juven), and a metabolic formula line (Phenex-1/2 for PKU, Ketonex-2 for MSUD, Propimex-2 for propionic/methylmalonic acidemia, RCF). Proprietary technology anchors include a 5-HMO prebiotic blend claimed as the closest to breast milk, extensively hydrolyzed protein formulas for cow's milk protein allergy, and amino acid-modified medical foods for rare inherited metabolic disorders. Collectively, the portfolio positions Similac as the #1 infant formula fed in U.S. hospitals, PediaSure as the #1 pediatrician-recommended children's nutrition brand, and Glucerna as the #1 doctor-recommended nutrition brand for people with diabetes.

The business operates a hybrid go-to-market model. Enterprise and institutional customers — primarily hospitals — order via phone (800-551-5838) or the e-Abbott.com portal under multi-year contractual terms, while individual consumers purchase through major pharmacy chains, grocery and mass retailers, and online marketplaces, with the Abbott Store providing direct-to-consumer home delivery for specialty items that are difficult to source in retail. Healthcare professionals are engaged through the Pediatric ProConnect clinician portal, the WebNova hospital partner platform, the Abbott Nutrition Health Institute (ANHI) for accredited continuing education, and a sales-representative sample distribution channel gated by NPI verification. Pricing is not publicly disclosed; consumer products follow unit pricing, institutional contracts run on multi-year terms, and insurance reimbursement is supported through the Pathway Plus program for qualifying medical nutrition products.

Abbott Nutrition Manufacturing holds the leading 9.6% share of the global meal replacement shake market and, combined with Mead Johnson, manufactures approximately half of all baby formula sold in the United States. The division is exposed to infant-formula regulatory and reputational risk — a 2022 Cronobacter contamination event at the Sturgis, Michigan facility triggered widespread recalls of Similac, Alimentum, and EleCare products, a $170 million U.S. sales decline in 2022, and a multi-year CDC investigation that was formally closed in September 2025. The portfolio is otherwise broadly diversified across consumer, patient, and institutional end markets, with complementary sub-brands covering routine feeding, food allergy, metabolic disorders, diabetes, dialysis, wound healing, and weight management.

Name

Abbott Nutrition Manufacturing

Legal name

Abbott Laboratories

Website

https://abbottnutrition.com

Company type

Private

Founded year

1888

Operating status

Operating

Headcount range

11–50 employees

Short description

Abbott Nutrition Manufacturing, a division of Abbott Laboratories, develops and markets science-based nutritional products including infant formulas (Similac), pediatric nutrition (PediaSure), adult nutrition (Ensure, Glucerna), metabolic and hypoallergenic formulas, serving consumers, healthcare professionals, and institutions globally.

Ownership category

akta.pro rank

Product category

Infant and Medical Nutrition Manufacturing

NAICS

Food Manufacturing (311), Perishable Prepared Food Manufacturing (311991)

SIC

Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Infant Formula & Specialized Dairy Nutrition Manufacturing (AFAKAKAJ)

akta.pro secondary industries

Specialty & Medical Infant Formula (Hypoallergenic, Lactose-Free, Metabolic) (CRADAEAB), Toddler & Growing-Up Milk (12+ months) (CRADAEAC), Baby Meals & Ready-to-Eat Foods (Pouches, Bowls, Refrigerated/Frozen) (CRADAEAG), Baby Feeding Supplements & Fortifiers (Probiotics, DHA/ARA, Vitamins) (CRADAEAI), Kids’ & baby/toddler prepared meals manufacturing (AFAKAHAL), Premature & Low-Birth-Weight Infant Formula Manufacturing (AFAHAHAE), Baby Nutrition for Special Diets (Gluten-Free, Kosher/Halal, Allergen-Controlled) (CRADAEAO), Functional Baby & Kids Foods Manufacturing (Fortified Infant/Toddler Foods, Kids Nutrition) (AFAKAJAJ)

Keywords

• Infant formula
• Pediatric nutrition
• Adult medical nutrition
• Metabolic formula
• Oral rehydration

Headquarters

HQ city

Columbus

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Nutrition Product Sales: Abbott Nutrition generates revenue through the sale of branded nutritional products including infant formulas (Similac), pediatric nutrition (PediaSure, EleCare), adult nutrition (Ensure, Glucerna), specialized medical foods (Juven, Nepro, metabolic formulas), and rehydration products (Pedialyte). Products are sold through retail, institutional/hospital, and direct-to-consumer channels.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Abbott Nutrition Manufacturing develops, produces, and markets science-based nutritional products spanning infant formulas (Similac), pediatric nutrition (PediaSure), adult nutrition (Ensure, Glucerna), specialized medical foods for metabolic disorders (Phenex, Ketonex, Propimex), and rehydration solutions (Pedialyte). Products are sold under multiple brand names through retail, hospital/institutional, and direct-to-consumer channels.

Product overview

Abbott Nutrition Manufacturing offers a comprehensive portfolio of nutritional products spanning infant nutrition, pediatric specialty nutrition, adult nutrition, and metabolic nutrition. The core products include Similac (infant formulas including specialized options with HMOs), PediaSure (children's nutritional drinks), Ensure (adult nutrition shakes and powders), Glucerna (diabetes management products), Nepro (dialysis nutrition), Pedialyte (rehydration solutions), EleCare/EleCare Jr (amino acid-based formulas for food allergies), and Juven (wound healing supplements). The metabolic nutrition line includes Phenex-1/Phenex-2 (PKU formulas), Ketonex-2 (MSUD formula), Propimex-2 (propionic/methylmalonic acidemia formula), and RCF (soy-based infant formula for carbohydrate intolerance). Additional products include tube feeding specialty nutrition (VITAL, JEVITY, PIVOT) and PROTALITY for muscle health during weight loss. Products are available in various formats including powders, liquids, and ready-to-drink shakes, serving infants, children, and adults with specialized dietary needs.

Differentiator

Problem solved

Functional benefit

Brands

• Similac: Infant formula brand, #1 brand fed in hospitals, offering formulas with 5 HMOs closest to breast milk
• PediaSure
• Ensure
• Glucerna
• Nepro
• Pedialyte
• EleCare
• Juven
• Phenex
• Ketonex
• Propimex
• RCF
• Protality
• Pediatric ProConnect
• WebNova

Quantifiable outcome

• PediaSure Grow & Gain is clinically proven to help kids grow (studied in children with and/or at risk for undernutrition, 2 servings per day)
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Mead Johnson (Reckitt Benckiser): Mead Johnson (Enfamil) is the other half of the U.S. infant formula duopoly alongside Abbott's Similac. Directly comparable as the leading competitor across routine, specialty, and metabolic infant formula categories, serving the same hospitals, pediatricians, and retail channels.
• Nestlé Nutrition (Gerber): Nestlé's Gerber is a global infant nutrition competitor with overlapping infant formula, baby food, and pediatric nutrition portfolios. Comparable on global scale, retail distribution, and brand-led go-to-market motion in the same end-customer segments.
• Danone (Nutricia): Danone's Nutricia and Aptamil brands are direct competitors in infant formula, metabolic nutrition, and medical nutrition across Europe and global markets. Particularly comparable in the metabolic and amino acid-based formula sub-categories where both compete.
• Perrigo Company: Perrigo manufactures store-brand and private-label infant formulas sold through U.S. retailers, directly competing with Abbott's Similac on price-sensitive shelf space. Also produces comparable pediatric nutritional products.

Broad incumbents

• Nestlé Health Science: Nestlé Health Science is the broader Nestlé division covering adult medical nutrition, dysphagia, and clinical nutrition — directly comparable to Abbott's Ensure, Nepro, and Juven adult/specialty portfolios. Operates at larger corporate scale with similar hospital GTM motion.
• Baxter International (Clinical Nutrition): Baxter competes in clinical and hospital-based nutrition via its parenteral and enteral nutrition portfolio. Comparable as a diversified medical products incumbent with overlapping hospital-channel nutrition offerings.

Emerging players

• B. Braun (Nutricomp): B. Braun's Nutricomp line competes in clinical nutrition and enteral feeding, overlapping with Abbott's VITAL, JEVITY, and PIVOT tube-feeding products. Comparable in the hospital enteral nutrition segment globally.
• Kate Farms: Kate Farms is a fast-growing plant-based medical nutrition company offering peptide and standard enteral formulas for adults and pediatrics. Comparable to Abbott's PediaSure Peptide, Vital Peptide, and EleCare in the specialty/malabsorption segment.
• Bobbie Baby: Bobbie is a venture-backed organic infant formula brand gaining share in the U.S. with a clean-label, European-inspired positioning. Comparable as a challenger in the premium infant formula category where Abbott's mass-market Similac faces growing competition.

Regional players

• HiPP: HiPP is a leading European organic infant formula and baby food manufacturer gaining traction in U.S. specialty channels post-2022. Comparable as a regional infant formula competitor with premium organic positioning targeting the same parental demographic.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/abbott-foods

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abbott Nutrition Manufacturing